Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profiles
US7321830B2 · kind B2 · utility
1Cited by
3References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 24, 2001 |
| Grant date | Jan 22, 2008 |
| Priority date | — |
| Expiry date | Sep 24, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A90/10
- WIPO fieldComputer technology
- WIPO sectorElectrical engineering
Abstract
The present invention relates to a computer system comprising a database for elucidating changes in gene expression in prostate tissue isolated from patients exhibiting different clinical states of prostate hyperplasia as compared to normal prostate tissue, as well as the identification of individual genes that are differentially expressed in diseased prostate tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.